Fusion status in patients with lymph node‐positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)-Reference-Cited by-同舟云学术

Fusion status in patients with lymph node‐positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)

Published:2018-05-24 Issue:15 Volume:124 Page:3201-3209
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Gallego Soledad¹^ORCID,Zanetti Ilaria²,Orbach Daniel³,Ranchère Dominique⁴,Shipley Janet⁵,Zin Angelica⁶,Bergeron Christophe⁴,de Salvo Gian Luca⁷,Chisholm Julia⁸,Ferrari Andrea⁹,Jenney Meriel¹⁰,Mandeville Henry C.⁸,Rogers Timothy¹¹,Merks Johannes H.M.¹²^ORCID,Mudry Peter¹³,Glosli Heidi¹⁴,Milano Giuseppe Maria¹⁵,Ferman Sima¹⁶,Bisogno Gianni²,

Affiliation:

1. Pediatric Oncology and Hematology, Children's Hospital Vall d'HebronBarcelona Spain

2. Padova University HospitalPadova Italy

3. Pediatric Oncology, SIREDO Oncology Center, Institute CurieParis Sciences and Letters UniversityParis France

4. IHOPE/Center Leon BerardLyon France

5. Institute of Cancer ResearchLondon United Kingdom

6. Pediatric Research Institute Citta della SperanzaPadova Italy

7. Clinical Trials and Biostatistics Unit, Veneto Oncologic Institute IOV‐IRCCSPadova Italy

8. The Royal Marsden National Health Service Foundation TrustSutton United Kingdom

9. National Tumor InstituteMilan Italy

10. Pediatric Oncology, Children Hospital for Wales Cardiff and Vale University Health BoardCardiff United Kingdom

11. University Hospitals Bristol National Health Service Foundation TrustBristol United Kingdom

12. Pediatric Oncology, Emma Children's Hospital‐Academic Medical CenterAmsterdam The Netherlands

13. Pediatric Oncology, University Children's Hospital BrnoBrno Czech Republic

14. Pediatric Oncology, Oslo University HospitalOslo Norway

15. Pediatric Oncology, Children's Hospital Bambino Gesu, IRCCSRome Italy

16. Pediatric Oncology, National Cancer InstituteRio de Janeiro RJ Brazil

Funder

Institute of Cancer Research

Fondazione Città della Speranza

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.31553

Reference34 articles.

1. Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V

2. Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV

3. European Intergroup Studies (MMT4-89 and MMT4-91) on Childhood Metastatic Rhabdomyosarcoma: Final Results and Analysis of Prognostic Factors

4. Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive overview of liquid biopsy applications in pediatric solid tumors;npj Precision Oncology;2024-08-03

2. A case of alveolar soft tissue sarcoma detected by ultrasound examination;Medical Ultrasonography;2024-06-21

3. Molecular Alterations in Pediatric Solid Tumors;Clinics in Laboratory Medicine;2024-06

4. Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG);Cancers;2024-02-29

5. Treatment of nasolabial fold rhabdomyosarcoma in children: A single‐institution experience;Head & Neck;2024-01-12